Free tool
Diagnostics stocks
We cover 2 companies grouped under the Diagnostics theme. The median market value in the group is $199.94M. Across the group, the median move over the past trading day is −0.33%. Price change over the past year runs from −29.1% to −16.5% across the middle 80 percent of the group, with a median of −22.8%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
2 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 0RAR.L | Stratec SE | $275.63M | Small cap | −14.98% |
| BVXP.L | Bioventix PLC | $124.26M | Small cap | −30.64% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.